| Pharmaceutical Information |
| Drug Name |
Altretamine |
| Drug ID |
BADD_D00088 |
| Description |
An alkylating agent proposed as an antineoplastic. It also acts as a chemosterilant for male houseflies and other insects. |
| Indications and Usage |
For use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination. |
| Marketing Status |
Prescription |
| ATC Code |
L01XX03 |
| DrugBank ID |
DB00488
|
| KEGG ID |
D02841
|
| MeSH ID |
D006585
|
| PubChem ID |
2123
|
| TTD Drug ID |
D02LPF
|
| NDC Product Code |
Not Available |
| Synonyms |
Altretamine | Hemel | Hexamethylmelamine | Hexinawas | Hexalen | Hexastat |
|
| Chemical Information |
| Molecular Formula |
C9H18N6 |
| CAS Registry Number |
645-05-6 |
| SMILES |
CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
